Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Oncol.

Sec. Genitourinary Oncology

Volume 15 - 2025 | doi: 10.3389/fonc.2025.1603069

A novel prognostic biomarker DUSP6 promote the malignant progression of bladder cancer through mTOR mediated mitophagy

Provisionally accepted
  • 1Second Clinical Medical College, Nanchang University, Nanchang, China
  • 2The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, China

The final, formatted version of the article will be published soon.

Bladder cancer (BC) is one of the most prevalent urinary malignant tumors that is intricately regulated by molecular pathways. Multiple studies have demonstrated a clear association between DUSP6 and malignant tumor progression; however, its role and underlying mechanisms in BC remain unclear.Here, we found that DUSP6 exhibits significantly elevated expression in BC tissues compared with normal tissues and is strongly associated with poor overall survival. Transcriptomic analysis revealed a robust correlation between DUSP6 expression and mitophagy, a selective form of autophagy crucial for maintaining mitochondrial integrity. In vitro and in vivo experiments demonstrated that knockdown of DUSP6 reduces tumor invasion, migration, and proliferation ability while enhancing mitophagy in BC cells. Notably, the anti-malignant effects of DUSP6 knockdown were partially reversed by the mitophagy inhibitor cyclosporin A. Mechanistically, DUSP6 modulates mitophagy by increasing the phosphorylation status of mTOR, a central autophagy regulator, and DUSP6 knockdown-induced mitophagy was partially restored after treatment with mTOR activator MHY1485.Our findings indicate that high DUSP6 expression promotes BC progression by inhibiting mTOR-mediated mitophagy, leading to a poor prognosis for BC patients. These insights suggest DUSP6 as a potential therapeutic target in the treatment of BC. B: The UMAP plot showed clustering of epithelial cells. Epithelial cells are divided into 15 clusters.C: DUSP6 expression in epithelial cells of tumor tissues is illustrated, with expression density plot at left and violin plot at right of DUSP6. D: The UMAP plot displayed that epithelial cells were separated into DUSP6+ epithelium and DUSP6-epithelial based on their expression. E: The volcano plot illustrated the differential expression genes between DUSP6+ epithelial cells and DUSP6-epithelial cells.F: The KEGG enrichment analysis for differential genes was performed. G: The GO enrichment analysis for differential genes was performed.

Keywords: Bladder cancer, DUSP6, mitophagy, prognostic, mTOR

Received: 31 Mar 2025; Accepted: 11 Aug 2025.

Copyright: © 2025 Huang, Zhou, Yu, Song, Deng, CHAO and Zeng. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Chongwei Zhou, Second Clinical Medical College, Nanchang University, Nanchang, China
Tao Zeng, Second Clinical Medical College, Nanchang University, Nanchang, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.